Quantcast

Latest Pfizer Stories

2014-10-23 08:36:57

KALAMAZOO, Mich., Oct. 23, 2014 /PRNewswire/ -- Metabolic Solutions Development Company, LLC (MSDC) announced today that it has appointed Robert L. Zerbe, MD to its Board of Managers. Dr. Zerbe co-founded and is chief executive officer of QuatRx Pharmaceuticals Company, a venture-backed drug development company that developed the recently launched product for postmenopausal dyspareunia, Osphena®. Prior to QuatRx, he served as Senior Vice President of Worldwide Clinical Research and...

2014-10-21 08:34:34

ALBANY, New York, October 21, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Hospital Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" the global hospital pharmaceuticals market was valued at USD 26.5 billion in 2013 and is estimated to reach USD 11.6 billion by 2020 declining with a CAGR of (10.5)% from 2014 to 2020. The report defines hospital pharmaceuticals as...

2014-10-20 20:24:32

LONDON, Oct. 20, 2014 /PRNewswire/ -- Future Prospects for Leading Companies Report DetailsDermatological drugs - new study showing you trends, R&D progress, and predicted revenuesWhere's the dermatological drugs market heading? Visiongain's brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there.Our 272-page report provides 169 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future...

2014-10-20 08:32:35

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, October 20, 2014 /PRNewswire/ -- Today, Analysts Review released its research reports regarding AbbVie Inc. (NYSE: ABBV), Gilead Sciences Inc. (NASDAQ: GILD), Pfizer Inc. (NYSE: PFE), Eli Lilly and Company (NYSE: LLY) and Aetna Inc. (NYSE: AET). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at:...

2014-10-17 12:28:58

DALLAS, October 17, 2014 /PRNewswire/ -- The Middle East and Africa Solid Organ Transplant Immunosuppressant Industry 2014 Deep Research Report is of 120 pages and published in October 2014. This is a professional and depth research report on Middle East and Africa Countries Solid Organ Transplant Immunosuppressant industry. Complete report is available at...

2014-10-16 08:31:22

DUBLIN, Oct. 16, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR(®), which is a central nervous system stimulant indicated for the treatment of Attention Deficit...

2014-10-15 08:30:48

BURLINGAME, Calif., Oct. 15, 2014 /PRNewswire/ -- Apexigen, Inc., a biopharmaceutical company discovering and developing innovative antibody drugs for the treatment of cancer and other life-threatening diseases, today announced the appointments of Ovid C. Trifan, MD, PhD as Vice President, Clinical Development and Amy Wong as Vice President, Finance. Dr. Trifan joins Apexigen from Onyx Pharmaceuticals with extensive expertise in oncology research and product development. Ms. Wong...

2014-10-14 16:26:37

LONDON, Oct. 14, 2014 /PRNewswire/ -- The BCC Research Tarceva Forecast is a quantitative forecast model in an easily accessible Microsoft Excel spreadsheet, segmented by specific parameters.The introductory sample of the Tarceva Forecast Model was already sent in the update earlier today. I have attached it again for your reference. The model features:- Market demand forecasts for Tarceva annually for the years 2010 to 2030 by volume (number of patients) and value (in U.S. dollars)-...

2014-10-14 16:26:13

LONDON, Oct. 14, 2014 /PRNewswire/ -- Use this report to:- Identify the major market trends and the factors driving or inhibiting the growth of the global pharmaceutical antibiotics market and its various submarkets.- Learn about developments of novel antibiotics to combat multidrug-resistant strains.- Gain information on the market structure, various subsegments of the global antibiotics market. Highlights- The global systemic antibiotics market was valued at $39.6 billion in 2013...

2014-10-14 00:21:13

TAMPA, Fla., Oct. 13, 2014 /PRNewswire-USNewswire/ -- International Society for Pharmaceutical Engineers (ISPE) announced today Pfizer Ireland Pharmaceuticals as the 2014 Facility of the Year Awards (FOYA) Overall Winner at the society's annual meeting in Las Vegas, NV. http://photos.prnewswire.com/prnvar/20120912/DC73253LOGO Pfizer Ireland's Network Strategy Implementation (NSI) Expansion Capacity project challenged the company to add capacity by re-purposing an existing...


Latest Pfizer Reference Libraries

Generalized Anxiety Disorder
2013-07-25 15:07:54

Generalized Anxiety Disorder (GAD) is an anxiety disorder with worry about normal, everyday situations such as finance, health and wellbeing in relationships (personal and work related) all lasting longer than six months. Symptoms The symptoms of GAD can include but are not limited to difficulty swallowing, rashes, shortness of breath, fidgeting, headaches, tension, nausea, etc. In order for GAD to be ruled as present, the symptoms and feelings must be experiences for at least six...

0_9f897835bb09adc2a84fda23893d87f8
2011-04-15 13:50:01

Clostridium difficile, also known as "CDF/cdf", or "C. diff", is a Gram-positive bacteria of the genus Clostridium that causes severe diarrhea and other intestinal disease when competing bacteria in the gut flora are wiped out by antibiotics. They are anaerobic, spore-forming rods and is the most serious cause of antibiotic-associated diarrhea and potentially to pseudomembranous colitis. C. difficile bacteria naturally resides in the gut of a small percentage of the adult population. Others...

More Articles (2 articles) »
Word of the Day
ween
  • To think; to imagine; to fancy.
  • To be of opinion; have the notion; think; imagine; suppose.
The word 'ween' comes from Middle English wene, from Old English wēn, wēna ("hope, weening, expectation"), from Proto-Germanic *wēniz, *wēnōn (“hope, expectation”), from Proto-Indo-European *wen- (“to strive, love, want, reach, win”).
Related